文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?

作者信息

Huang Jiaofeng, Kumar Rahul, Wang Mingfang, Zhu Yueyong, Lin Su

机构信息

Liver Research Center of the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China, 350001.

Department of Gastroenterology and Hepatology, Duke-NUS Academic Medical Centre, Changi General Hospital, Singapore.

出版信息

J Hepatol. 2020 Nov;73(5):1265-1267. doi: 10.1016/j.jhep.2020.06.016. Epub 2020 Aug 17.

DOI:10.1016/j.jhep.2020.06.016
PMID:32819754
Abstract
摘要

相似文献

[1]
MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?

J Hepatol. 2020-11

[2]
Metabolic dysfunction-associated fatty liver disease: a new clearer nomenclature with positive diagnostic criteria.

Acta Gastroenterol Belg. 2020

[3]
Reply to: correspondence regarding "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement": Bringing evidence to the NAFLD-MAFLD debate.

J Hepatol. 2020-12

[4]
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa.

Lancet Gastroenterol Hepatol. 2021-1

[5]
Concordance between MAFLD and NAFLD diagnostic criteria in 'real-world' data.

Liver Int. 2020-11

[6]
Metabolic dysfunction-associated fatty liver disease - How relevant is this to primary care physicians and diabetologists?

Prim Care Diabetes. 2022-4

[7]
Authors' response to 'Concordance of MAFLD and NAFLD diagnostic criteria in "real-world" data'.

Liver Int. 2020-11

[8]
The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.

Lancet Gastroenterol Hepatol. 2021-1

[9]
Reply to: Correspondence on "A new definition for metabolic associated fatty liver disease: an international expert consensus statement": MAFLD: Moving from a concept to practice.

J Hepatol. 2020-11

[10]
The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.

J Hepatol. 2021-5

引用本文的文献

[1]
The utility of an artificial intelligence model based on decision tree and evolution algorithm to evaluate steatotic liver disease in a primary care setting.

Braz J Med Biol Res. 2025-6-16

[2]
The association of advanced lung cancer inflammation index with non-alcoholic fatty liver disease in NHANES 2017-2020.

Front Med (Lausanne). 2025-4-14

[3]
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target.

Liver Res. 2022-9-19

[4]
Prevalence of Metabolic-associated Fatty Liver Disease in Mexico and Development of a Screening Tool: The MAFLD-S Score.

Gastro Hep Adv. 2022-3-30

[5]
The Global Epidemic of Metabolic Fatty Liver Disease.

Curr Cardiol Rep. 2024-4

[6]
Recent advances in NAFLD: current areas of contention.

Fac Rev. 2023-5-2

[7]
Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis.

Hepatol Int. 2023-6

[8]
Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications.

Hepatol Int. 2023-4

[9]
Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?

Hepatol Forum. 2020-9-21

[10]
Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity.

Diabetes Metab Res Rev. 2022-10

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索